EWSR1 and Ewing sarcoma: Additionally, tumor lysate-pulsed DC vaccines effectively activate the immune system, inhibiting osteosarcoma growth (Kawano et al., 2015), while DCs pulsed with EWS/FLI-l peptide epitopes exhibit significant capabilities in tackling Ewing’s sarcoma (Peng et al., 2014).